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This international multicenter, prospective, observational study aimed at identifying predictors
of short-term clinical outcome in patients with prolonged disorders of consciousness (DoC)
due to acquired severe brain injury.
Methods
Patients in vegetative state/unresponsive wakefulness syndrome (VS/UWS) or in minimally
conscious state (MCS) were enrolled within 3 months from their brain injury in 12 specialized
medical institutions. Demographic, anamnestic, clinical, and neurophysiologic data were col-
lected at study entry. Patients were then followed up for assessing the primary outcome, that is,
clinical diagnosis according to standardized criteria at 6 months postinjury.
Results
We enrolled 147 patients (44 women; mean age 49.4 [95% confidence interval 46.1–52.6] years;
VS/UWS 71, MCS 76; traumatic 55, vascular 56, anoxic 36; mean time postinjury 59.6
[55.4–63.6] days). The 6-month follow-up was complete for 143 patients (VS/UWS 70; MCS
73). With respect to study entry, the clinical diagnosis improved in 72 patients (VS/UWS 27;
MCS 45). Younger age, shorter time postinjury, higher Coma Recovery Scale–Revised total
score, and presence of EEG reactivity to eye opening at study entry predicted better outcome,
whereas etiology, clinical diagnosis, Disability Rating Scale score, EEG background activity,
acoustic reactivity, and P300 on event-related potentials were not associated with outcome.
Conclusions
Multimodal assessment could identify patients with higher likelihood of clinical improvement in
order to help clinicians, families, and funding sources with various aspects of decision-making. This
multicenter, international study aims to stimulate further research that drives international con-
sensus regarding standardization of prognostic procedures for patients with DoC.
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Disorders of consciousness (DoC)—vegetative state/
unresponsive wakefulness syndrome (VS/UWS)1,2 and mini-
mally conscious state (MCS)3—can persist for longer than 28
days (i.e., prolonged DoC).4 Reliable prognostic markers are
necessary for assisting all involved parties on decisions about
patient management.5,6 Many prognostic studies have in-
vestigated clinical and neurophysiologic indicators in comatose
patients.7,8 Among these predictors, bilateral absence of the
cortical component on somatosensory evoked potentials
(SEPs) is considered the most accurate marker for poor
prognosis in anoxic comatose patients.8,9 A recent study ex-
amined the prognostic value of SEPs in anoxic VS/UWS at 1–3
months after brain injury,10 confirming their utility in the re-
habilitative setting. Recent longitudinal studies demonstrated
the prognostic value of the Coma Recovery Scale–Revised
(CRS-R)10,11 and of EEG background activity12,13 in the sub-
acute phase. However, the majority of these prognostic studies
evaluated individual clinical or neurophysiologic predictors, an
approach that precludes identification of the independent
predictive role of each biomarker.14 Moreover, most of the
available evidence for prognostication has been gathered in
single-center studies that may be susceptible to sampling bias.
On this basis, the Special Interest Group on DoC (DoC-SIG)
of the International Brain Injury Association (IBIA) (see
internationalbrain.org) launched a multicenter, longitudinal
study on a cohort of patients with prolonged DoC to evaluate
the prognostic value of demographic, anamnestic, clinical, and
multimodal neurophysiologic findings on clinical outcome at
6 months postinjury.
Methods
Design of the study
Thepresent prospective, observational studywas conducted in the
framework of the IBIA DoC-SIG and involved 12 medical insti-
tutions with expertise in diagnosis and care of adults after severe
acquired brain injuries. The participating units (intensive care
units, n = 2; intensive specialized rehabilitation units for postacute
patients, n = 8; neurology departments, n = 2) were located in
Europe (n = 10), North America (n = 1), and Asia (n = 1).
The study was conducted in 3 phases. In the first phase, a team
of multidisciplinary investigators from all participating sites
identified clinical and neurophysiologic measures that are
feasible to collect in most clinical settings10,12,13,15–17 and po-
tentially informative for the purposes of the study, as suggested
by recent recommendation statements for prognosis in adults
with prolonged DoC.4 All participating centers had well-
established expertise in using the selected clinical and neuro-
physiologic tools. In the second phase, the skilled examiners,
selected among the staff of each participating center for their
long-standing experience in the evaluation of patients with
DoC, participated in several conference calls to ensure the
consistency of administration and scoring of the clinical scales,
as well as of acquisition and analysis of the neurophysiologic
tests selected for the study. In the third phase, all participating
centers enrolled a convenience sample of patients with pro-
longed DoC from January to December 2017 and followed
them clinically until 6 months after brain injury.
Study population
Inclusion criteria were (1) age 18–80 years; (2) clinical di-
agnosis of VS/UWS or MCS, according to standard diagnostic
criteria1,3; (3) anoxic, traumatic, or vascular (i.e., hemorrhagic or
ischemic) etiology; (4) time postinjury ranging from 1 to 3
months. Exclusion criteria were (1) previous history of acquired
brain injury or psychiatric or neurodegenerative diseases; (2)
coexisting neoplasms, severe organ dysfunction, or unstable
clinical condition (e.g., hemodynamic instability or severe re-
spiratory failure).
Clinical assessment
At study entry, each center collected patient demographic data
(e.g., age, sex) and information about medical history (e.g., eti-
ology, time postinjury). Within 1 week from study entry, all
patients were assessed by skilled investigators by means of re-
peated (at least 3 in a week) CRS-R evaluations15 in order to
confirm the patients’ clinical diagnosis18 and to determine the
best CRS-R total score. Moreover, hospital staff assessed patients’
behavioral response to nociceptive stimuli and functional dis-
ability level by means of the Nociception Coma Scale–Revised
(NCS-R)19 and Disability Rating Scale (DRS)20 total scores,
respectively. Patients were clinically followed up at 6months after
brain injury by repeated CRS-R conducted by the same clinical
staff from their hospital stay or, if after discharge, in an outpatient
follow-up clinic, at home, or in chronic care facilities.
Neurophysiologic examination
Skilled neurophysiologists blind to the patient’s clinical di-
agnosis recorded and analyzed multimodal neurophysiologic
Glossary
APG = anterior-posterior gradient;AUC = area under the curve;BCa = bias corrected and accelerated;CI = confidence interval;
CRS-R = Coma Recovery Scale–Revised;DoC = Disorders of consciousness;DoC-SIG = Special Interest Group on Disorders
of Consciousness; DRS = Disability Rating Scale; DS = diffuse slowing; ERP = event-related potential; IBIA = International
Brain Injury Association; IPS = intermittent photic stimulation; LASSO = least absolute shrinkage and selection operator; LV =
low voltage;MCS = minimally conscious state;MiA = mildly abnormal;MoA = moderately abnormal; NCS-R = Nociception
Coma Scale–Revised; SEP = somatosensory evoked potential; VIF = variance inflation factor; VS/UWS = vegetative state/
unresponsive wakefulness syndrome.
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data including standard EEG, SEPs, and event-related po-
tentials (ERPs) within 15 days from study entry, according to
the shared protocols.
The standard EEGwas recorded by 19 electrodes placed on the
patients’ scalp according to the international 10–20 system
(Fp1, Fp2, F7, F8, F3, F4, C3, C4, T3, T4, P3, P4, T5, T6, O1,
O2, Fz, Cz, Pz). EEG was recorded for a minimum of 35
minutes according to standard procedure of eye-closed re-
cording during a waking rest with filter settings 0.53–70Hz and
notch filter on. Eyes closure for the analysis of predominant
activity was obtained with forced eye closing by a cotton wool
applied by paper patch in wakefulness condition (spontaneous
eye opening). A morning EEG was acquired bedside after
customary nursing procedures and (at least) 10 hours after
administration of drugs acting on the CNS, such as myor-
elaxants and sedative drugs (e.g., benzodiazepines, neurolep-
tics) in order to optimize vigilance. Long-term antiepileptic
treatment was continued, if clinically indicated.
EEG background activity was classified into 5 severity cate-
gories according to recently proposed criteria for patients with
DoC21: (1) normal EEG activity, in presence of predominant
posterior alpha rhythm and of the anterior-posterior gradient
(APG), without focal or hemispheric slowing or epileptiform
abnormalities; (2) mildly abnormal (MiA) EEG, characterized
by predominant posterior theta activity (>20 μV), symmetric or
not, with frequent (10%–49% of recording) posterior alpha
rhythms; (3) moderately abnormal (MoA) EEG, characterized
by predominant posterior theta activity (>20 μV), symmetric or
not, poorly organized APG, even with rare (<1% of recording)
or occasional (1%–9% of recording) posterior alpha rhythms;
(4) diffuse slowing (DS), defined as an EEG background ac-
tivity with predominant diffuse theta or theta/delta rhythms at
amplitude >20 μV, without APG; (5) low voltage (LV) EEG,
defined as a predominant EEG activity (theta or delta) <20 μV
over most brain regions.
To analyze EEG reactivity to external stimulation, 5 kinds of
stimuli were randomly administered (each stimulus 3 times)
during EEG recording: (1) eye opening and (forced) eye
closing; (2) tactile stimuli (wiping on the back of right and left
forearm with cotton wool); (3) noxious stimulation (pressing
fingernail beds on each hand); (4) acoustic stimulation (hand
clapping); (5) intermittent photic stimulation (IPS) by 1, 3, 6,
9, 12, 15, 18, and 21 Hz flashes in 10-second trains presented
through closed eyelids with 5-second interval between 2
trains. We analyzed 3-second EEG activity after stimulus
onset to detect any clear and reproducible change in fre-
quency or amplitude in cerebral activity that could be ascribed
to multisensory stimulation.22 EEG reactivity to each kind of
stimulus was defined as present if it was recorded in at least
one out of 3 trials. The effect of IPS was considered as present
if the physiologic photic driving response was elicited over
posterior region. Not clearly detectable EEG responses to
stimuli were considered as absent. If artifacts were present in
more than 50% of EEG recording time, EEG acquisition was
repeated within 1 week. When no EEG of sufficient quality
could be obtained, EEG data were excluded from analysis.
SEPs were recorded during electrical stimulation of the pa-
tients’ median nerve, delivered by means of a bipolar surface
electrode placed on the patients’ right and left wrists. Stim-
ulation intensity was set to 4/3 of individual motor threshold.
Each pulse lasted 0.2 ms and was delivered with a 3 Hz rate
(time base 50 ms; bandwidth 5 Hz–3 KHz). Recording
stainless steel needle electrodes or silver cups were placed at
Erb’s point (referred to contralateral Erb’s point), spinous
process Cv7 (referred to anterior neck), C39 and C49 (re-
ferred to each other and to Fz). At least 2 averages of 300
responses were repeated and superimposed. The presence or
absence of N20/P25 cortical components was evaluated.23
ERPs were obtained by means of a simple oddball paradigm
using auditory stimulation.24 Two randomly intermixed tones
(not-target: 1,000Hz, overall probability 80%; target: 2,000Hz,
overall probability 20%) were delivered binaurally through
earphones at a rate of 1 tone (90 dB SPL, 50 ms plateau time, 2
ms rise and fall slope) every 1.1 seconds. Each patient was asked
to keep a mental count of the rare (target) tones while ignoring
the frequent (not-target) tones. This procedure was conducted
independently of patients’ language comprehension abilities on
the behavioral examination.25 EEG activity was continuously
recorded (band pass filtered at 0.1–100 Hz; digitized at a
sampling rate of 1,024Hz) from at least 3 (Fz, Cz, and Pz) scalp
electrodes (10–20 International System) all referred to linked
earlobes, with the ground electrode positioned on Fpz. In the
presence of a N100, detection of late cortical component P300
was evaluated by visual identification by a trained neurophys-
iologist based on latency (280–500 ms) and scalp topography
central to parietal (80–150 ms).24
Outcome definition
The primary outcome was a patient’s clinical diagnosis at 6
months postinjury. Clinical diagnosis was established according
to the standardized clinical criteria for VS/UWS,1,2 MCS, and
for emergence from MCS,3 confirmed by CRS-R.4 For the
purpose of statistical analysis, we classified a patient as im-
proved if there was an improvement in clinical diagnosis with
respect to study entry (i.e., patient in MCS at baseline who
emerged from MCS, and patient in VS/UWS at baseline who
progressed to MCS or eventually regained full consciousness).
We classified a patient as not improved if the clinical diagnosis
worsened (i.e., patient in MCS at baseline who worsened to
VS/UWS), or did not improve, or if the patient died.
Data management and statistical analyses
Referring staff from all participating sites entered, through a
forced-choice format, patient data into a secure, password-
protected, electronic database uploaded onto a shared folder.
Data entry fields for each patient were referred to by an anon-
ymous code that did not allow the identity of the patient to be
traced, in order to protect confidentiality and to safeguard pri-
vacy. Regular checks on data entry were periodically carried out
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by the coordinator research group (A.E., S.F., A.M.). If any
missing data or inconsistencies were detected, the center in
question was encouraged to check it thoroughly. When com-
pleted, the database was removed from the online shared folder
and kept on file safely stored by the principal investigator (A.E.).
Statistical analyses were performed by the coordinator re-
searcher group (A.E., A.M., L.T.). Descriptive statistics were
presented as means and 95% confidence intervals (CIs) for
continuous variables and as frequencies for categorical vari-
ables. For between-group comparisons, continuous variables
were submitted to Shapiro-Wilk test for normality. As scores of
several variables departed significantly from the norm, we
compared baseline findings as a function of diagnosis (VS/
UWS vs MCS), of etiology, and of outcome (improved vs not
improved) by nonparametric Mann-Whitney U test for con-
tinuous variables and χ2 for categorical variables. The level of
significance was adjusted for multiple comparisons using the
false discovery rate correction; corrected p was set at 0.05 (2-
tailed). Effect size for nonparametric statistics was expressed as
η2 (95% CI), and for χ2 statistics as Cramer V (95% CI),
computed by means of a bootstrapping procedure (1,000
samples; CI = BCa [bias corrected and accelerated]). The re-
sults were considered statistically significant when corrected p
was <0.05 and 0 <η2/V (95% CI) < 1.
To investigate the relationships between predictors at baseline
and outcome at 6 months postinjury, we applied 2 regression
models. Prior to any regression analysis, we tested multi-
collinearity among the predictors by checking for the variance
inflation factor (VIF) and tolerance. A VIF value less than 10 or
tolerance (that is, the inverse of the VIF) less than 0.1 should not
involve any issues withmulticollinearity; in general, the lower the
VIF value, the smaller the correlation among variables.26
Then, we used a standard logistic regression model in which we
included the selected variables as independent predictors and the
outcome (improved = 1; not improved = 0) as the dependent
variable. However, since standard regressionmodelsmight suffer
from overfitting, we also used a penalized regression model
(least absolute shrinkage and selection operator [LASSO]) as an
additional analysis. In the LASSO model, coefficients are biased
from a penalty term in order to increase the predictive accuracy.
The applied penalty could shrink to zero and then pull out from
the final model factors whose original predictive value was low,
thus including only the most important variables. The degree of
shrinkage was determined by a 10-fold cross-validation. No p
values are reported for the LASSO method, which does not
provide tests of significance, whereas we reported model fit ac-
curacy for both logistic and LASSO regression models. More-
over, model fit for the logistic regression was assessed by means
of the Hosmer-Lemeshow goodness of fit test, for which a p
value less than 0.05 suggests a poor fit. The Nagelkerke pseudo-
R2, which indicates the amount of variability accounted by all
predictors in the model, was also computed. For evaluating the
discrimination ability of the logistic regression model, the area
under the curve (AUC) of the receiver operating characteristic
curve was obtained. Accuracy of predictors of the logistic re-
gression model was also assessed by a bootstrapping procedure
(1,000 samples; CI = 95%; BCa).
All continuous variables were standardized prior to regression
analyses. Moreover, as the LASSO model only deals with
dichotomic categorical variables, and for the sake of consistency,
in both the standard and the LASSO regressions multichotomic
variables categorized as follows. For etiology, we contrasted
traumatic vs nontraumatic (i.e., anoxic and vascular) brain injury,
as often found in the literature.1,6 As regards background
EEG patterns and consistent with recent literature,21 we con-
trasted patterns with residual alpha rhythm (normal,MiA,MoA)
vs patterns lacking alpha rhythm (DS, LV). Possible missing data
were handled by listwise deletion. As this conservative procedure
model limited the analysis to patients for whom all relevant data
were available, we had to perform the same regression analyses
twice, including or excluding ERP as an independent variable
(ERPs were available for a subset of patients; see below). The
level of significance was set at 0.05 (2-tailed).
In presenting the results, we focused on the logistic re-
gression model and added the LASSO results as auxiliary;
moreover, we also presented the main concordances and
discordances between the logistic and the LASSO model.
Statistical analyses were performed by IBM SPSS Statistics v.
25 (IBM Corp., Armonk, NY) and R version 3.5.3 (R
Foundation for Statistical Computing, Vienna, Austria), in-
cluding the R packages glmnet and caret for the LASSO
model.
Standard protocol approvals and
patient consents
The institutional review board of the coordinating center and of
each center involved in the study reviewed and approved the
same outline of the project, shared by all centers and translated
in the respective languages. This study was then approved by
the ethical standards committee of the coordinator center and
of each center involved in the study, and performed according
to the ethical standards of the Declaration of Helsinki (1964)
and its later amendments. The surrogate decision-makers of the
patients enrolled in the study provided their written informed
consent after a semiformalized interview in which the purposes,
procedures, and time points of the longitudinal study were
clearly explained. The original forms were collected and stored
at each participant center.
Data availability
Any anonymized data not published within the article will be
shared upon request from any qualified investigator.
Results
Patient sample
Out of 194 patients screened for the study, 147 patients with
DoC fulfilled the selection criteria (figure). Demographic and
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clinical data for each diagnostic group are reported in table 1.
Patients in MCS showed significantly higher total scores for
CRS-R (U = 132.0; corrected p < 0.001; η2 = 0.68 [0.62–0.74])
and NCS-R (U = 1,261.5; corrected p < 0.001; η2 = 0.22
[0.16–0.27]) and lower scores for DRS (U = 942.5; corrected p
< 0.001; η2 = 0.32 [0.27–0.38]) than patients in VS/UWS;
patients in MCS did not differ from patients in VS/UWS in
terms of age, sex, etiology, or time postinjury (all corrected p >
0.1). Regarding etiology, patients with traumatic brain injury
were significantly younger than patients with anoxic brain in-
jury (U = 365.0; corrected p < 0.001; η2 = 0.28 [0.19–0.37])
and vascular insults (U = 393.5; corrected p < 0.001; η2 = 0.41
[0.34–0.49]; table 1).
Neurophysiologic findings (available data: EEG background
activity = 94.5%; reactivity to eye opening = 93.9%; reactivity to
tactile stimulation = 88.4%; reactivity to acoustic stimulation =
95.2%; reactivity to nociceptive stimulation = 87.7%; reactivity
to IPS = 90.4%; SEP = 58.5%; ERP = 53.6%; table 2) showed
that the frequency of normal, MiA, MoA, DS, and LV patterns
of EEG background activity significantly differed betweenMCS
and VS/UWS (χ24,139 = 25.36; corrected p < 0.001; V = 0.42
[0.29–0.61]), and among the 3 etiologies, as a better EEG
background organization was observed in MCS with respect to
VS/UWS and in traumatic (χ24,139 = 32.92; corrected p <
0.001; V = 0.62 [0.43–0.80]) and vascular (χ24,139 = 36.60;
corrected p < 0.001; V = 0.63 [0.46–0.80]) etiology vs anoxic
brain injury. EEG reactivity to eye opening and closing was
more frequent in traumatic than in anoxic patients (χ21,138 =
7.59; corrected p = 0.006; V = 0.30 [0.09–0.47]), whereas
reactivity to acoustic, tactile, nociceptive, and intermittent
photic stimulations did not differ among diagnostic and etio-
logic groups. The cortical component P300 on ERP was sig-
nificantly more frequent in MCS than in VS/UWS (χ21,75 =
8.13; corrected p = 0.004; V = 0.32 [0.12–0.53]; table 2).
Clinical evolution at 6-month follow-up
The 6-month follow-up (mean days from the brain injury =
180.31 ± 11.27) was complete for 143 patients (97.2% of the
sample). Four patients dropped out from the study because of
transfer to other care institution/home (n = 2) or revoked legal
guardians’ consent for study participation (n = 2). Seventy-one
patients (49.6%) were classified as not improved; among them,
4 patients declined fromMCS to VS/UWS (5.6%), 52 patients
Table 1 Demographic and clinical characteristics of patients at study entry as a function of diagnosis and etiology
Total
Clinical diagnosis Etiology
VS/UWS MCS Traumatic Vascular Anoxic
N 147 71 76 55 56 36
Age, ya 49.4 (46.1–52.6) 51.7 (47.1–56.3) 47.2 (42.6–51.9) 33.8 (29.3–38.3) 60.5 (56.6–64.4) 55.9 (50.4–61.4)
F/M 44/103 21/50 23/53 11/44 22/34 11/25
Clinical diagnosis,
VS-UWS/MCS
— — — 23/32 26/30 22/14
TPI, d 59.6 (55.4–63.6) 59.8 (53.7–65.9) 59.4 (53.7–65.1) 59.9 (52.8–67.0) 57.8 (51.0–64.6) 61.9 (53.8–69.9)
CRS-R total scoreb 8.6 (7.8–9.4) 4.6 (4.2–5.0) 12.4 (11.6–13.3) 9.6 (8.1–11.0) 8.6 (7.3–9.9) 7.3 (5.9–8.7)
NCS-R total scoreb 2.9 (2.6–3.2) 2.1 (1.8–2.4) 3.7 (3.3–4.1) 3.2 (2.7–3.7) 2.7 (2.3–3.2) 2.8 (2.2–3.4)
DRS total scoreb 23.8 (23.3–24.3) 25.4 (25.0–25.9) 22.3 (21.7–23.0) 23.2 (22.5–24.0) 24.0 (23.1–24.8) 24.6 (23.8–25.3)
Abbreviations: CI = confidence interval; CRS-R = Coma Recovery Scale–Revised; DRS = Disability Rating Scale; FDR = false discovery rate; MCS = minimally
conscious state; NCS-R = Nociception Coma Scale–Revised; TPI = time postinjury; VS/UWS = vegetative state/unresponsive wakefulness syndrome.
Descriptive data are reported as mean (95% CI) for continuous variables and as counts for categorical variables. Univariate statistics are based upon the
Mann-Whitney test or χ2 test, as appropriate, and relative effect size.
a Significant differences among etiologic groups for FDR-corrected p < 0.05 rate and for 0 < η2/V (95% CI) < 1.
b Significant differences between diagnostic groups for FDR-corrected p < 0.05 rate and for 0 < η2/V (95% CI) < 1.
Figure Study flowchart
DoC = disorders of consciousness; eMCS = emergence from minimally
conscious state.
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(32 in VS/UWS, 45.0%; 20 in MCS, 28.2%) did not change
their clinical diagnosis, and 11 patients in VS/UWS (15.5%)
and 4 in MCS (5.6%) died. No patients died because of
withdrawal of life-sustaining therapy27; death was due to severe
medical complications (e.g., sepsis, acute respiratory distress,
gastrointestinal bleeding, cardiac arrest) despite life-sustaining
treatments. Among the 72 patients (50%) classified as im-
proved, 20 in VS/UWS at baseline progressed to MCS
Table 2 Distribution of neurophysiologic findings at study entry as a function of diagnosis and etiology
Total
Clinical diagnosis Etiology
VS/UWS MCS Traumatic Vascular Anoxic
EEG background activitya,b 139 69 70 49 54 36
Normal 6 0 6 2 4 0
Mildly abnormal 27 5 22 15 8 4
Moderately abnormal 35 17 18 17 16 2
Diffuse slowing 45 32 13 12 24 9
Low voltage 26 15 11 3 2 21
Reactivity to eye opening, P/Ab 43/95 16/53 27/42 20/28 18/36 5/31
Reactivity to tactile stimuli, P/A 19/111 10/58 9/53 4/41 8/46 7/24
Reactivity to acoustic stimuli, P/A 35/105 13/56 22/49 13/37 17/37 5/31
Reactivity to nociceptive stimuli, P/A 34/95 16/51 18/44 9/36 18/36 7/23
Reactivity to IPS, P/A 25/108 15/53 10/55 8/40 11/43 6/25
N20 on SEP, P/A 65/21 32/15 33/6 17/12 29/4 19/5
P300 on ERP, P/Aa 40/35 12/22 28/13 11/10 21/13 8/12
Abbreviations: CI = confidence interval; ERP = event-related potential; FDR = false discovery rate; MCS = minimally conscious state; IPS = intermittent photic
stimulation; P/A = present/absent; SEP = somatosensory evoked potential; VS/UWS = vegetative state/unresponsive wakefulness syndrome.
Data are reported as counts. Univariate statistics are reported based upon the χ2 test and relative effect size.
a Significant differences between diagnostic groups for FDR-corrected p < 0.05 rate and for 0 < V (95% CI) < 1.
b Significant differences among etiologic groups for FDR-corrected p < 0.05 rate and for 0 < V (95% CI) < 1.
Table 3 Demographic and clinical characteristics of patients at study entry as a function of 6-month outcome
Total (n = 143) Not improved (n = 71) Improved (n = 72) η2/V (95% CI)
Age, y 49.8 (46.6–53.1) 55.4 (50.9–59.9) 44.4 (40.0–48.8) 0.08 (0.02 to 0.13)a
F/M 42/101 27/44 15/57 0.18 (0.03 to 0.34)a
Clinical diagnosis, VS-UWS/MCS 70/73 43/28 27/45 0.23 (0.06 to 0.39)a
Etiology 0.26 (0.09 to 0.44)a
Traumatic 52 18 34
Vascular 55 28 27
Anoxic 36 25 11
TPI, d 59.3 (55.2–63.5) 67.0 (61.2–72.8) 51.8 (46.2–57.4) 0.1 (0.04 to 0.15)a
CRS-R total score 8.5 (7.7–9.3) 6.8 (6.0–7.8) 10.1 (8.9–11.3) 0.11 (0.05 to 0.16)a
NCS-R total score 2.9 (2.6–3.2) 2.6 (2.3–3.0) 3.1 (2.7–3.5) 0.02 (−0.04 to 0.07)
DRS total score 23.9 (23.4–24.3) 24.6 (24.2–25.1) 23.1 (22.3–23.9) 0.07 (0.01 to 0.12)a
Abbreviations: CI = confidence interval; CRS-R = Coma Recovery Scale–Revised; DRS = disability rating scale; FDR = false discovery rate; MCS = minimally
conscious state; NCS-R = Nociception Coma Scale–Revised; TPI = time postinjury; VS/UWS = vegetative state/unresponsive wakefulness syndrome.
Descriptive data are reported as mean (95% CI) for continuous variables and as counts for categorical variables. Univariate statistics are based upon the
Mann-Whitney test or χ2 test, as appropriate, and relative effect size.
a Significant variables (based on FDR-corrected p < 0.05 rate and on 0 < η2/V [95% CI] < 1) and relative effect size.
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(27.8%), whereas 7 patients in VS/UWS at baseline (9.7%) and
45 patients in MCS at baseline (62.5%) emerged from MCS.
Predictors of 6-month outcome
Univariate analyses showed that improved patients had signif-
icantly younger age (U = 1,729.0; corrected p = 0.001) and
shorter time postinjury (U = 1,632.5; corrected p < 0.001) at
study entry than patients who did not improve. Moreover,
better 6-month prognosis was associated with male sex (χ21,143
= 5.09; corrected p = 0.02), MCS diagnosis (χ21,143 = 7.60;
corrected p = 0.006), and traumatic etiology (χ22,143 = 10.37;
corrected p = 0.006). Improved patients had higher CRS-R
total score (U = 1,592.0; corrected p < 0.001) and lower DRS
total score (U = 1799.0; corrected p = 0.002) at study entry
than patients who did not improve, whereas the 2 prognostic
groups did not differ in the NCS-R total score (corrected p >
0.1; table 3).
Regarding the neurophysiologic findings (table 4), the patterns
of EEG background activity significantly differed between im-
proved and not improved patients (χ24,137 = 16.93; corrected p
= 0.002), as better EEG background organization at baseline
was associated with better outcome. Moreover, EEG reactivity
to eye opening and closing (χ21,136 = 11.47; corrected p =
0.001) and to acoustic stimuli (χ21,136 = 8.07; corrected p =
0.004) was significantly more frequent in patients who im-
proved, whereas reactivity to tactile, nociceptive, and in-
termittent photic stimulations did not discriminate between the
outcomes (all corrected p > 0.1). The presence of cortical
component P300 on ERP was significantly more frequent in
improved patients (χ21,74 = 7.74; corrected p = 0.005), whereas
the presence of N20 wave on SEP was not associated with
outcome (corrected p > 0.1).
Prior to performing regression analyses, we verified that no
collinearity issues were present among the selected predictors
(VIF ranging from 1.10 to 4.53; tolerance values ranging from
0.22 to 0.90).
Standard logistic regression analysis on improvement of clinical
diagnosis with age, sex, etiology, time postinjury, entry di-
agnosis, CRS-R and DRS total scores, EEG background ac-
tivity, EEG reactivity to eye opening and to acoustic stimuli,
and ERP as predictors was performed on 72 patients in whom
all data were collected. Regression analysis provided a signifi-
cant final model (likelihood ratio χ2 = 53.36, df = 11, p < 0.001)
with 87.5% accuracy. In this model, younger age, shorter time
postinjury, higher CRS-R total score, and presence of EEG
reactivity to eye opening were significantly associated with a
better outcome, whereas sex, etiology, clinical diagnosis, DRS
total score, EEG background activity and reactivity to acoustic
stimuli, and presence of P300 on ERP at study entry were not
(table 5). The bootstrapping results were deemed to be very
biased (biases ranging from −416.34 to 218.83). However, this
logistic regression showed a good model fit as indicated by the
Hosmer-Lemeshow test (p = 0.11). Predictors in this model
accounted for the 69.9% of variability in themodel (Nagelkerke
pseudo-R2 = 0.699), and AUCwas 0.94 (95%CI [0.89–0.99]).
The LASSO model provided a similar model fit accuracy
(87.5%) and substantially confirmed the logistic regression
Table 4 Neurophysiologic findings at baseline as a function of 6-month outcome
Total Not improved Improved V (95% CI)
EEG background activity 137 68 69 0.35 (0.16–0.56)a
Normal 6 2 4
Mildly abnormal 27 9 18
Moderately abnormal 35 12 23
Diffuse slowing 44 25 19
Low voltage 25 20 5
Reactivity to eye opening, P/A 43/93 12/55 31/38 0.29 (0.12–0.44)a
Reactivity to tactile stimuli, P/A 19/110 9/53 10/57 0.00 (0.00–0.00)
Reactivity to acoustic stimuli, P/A 35/101 10/57 25/44 0.24 (0.07–0.38)a
Reactivity to nociceptive stimuli, P/A 33/95 14/47 19/48 0.06 (0.00–0.27)
Reactivity to IPS, P/A 25/107 11/54 14/53 0.05 (0.00–0.27)
N20 on SEP, P/A 65/21 31/12 34/9 0.08 (0.00–0.34)
P300 on ERP, P/A 39/35 13/23 26/12 0.32 (0.08–0.54)a
Abbreviations: CI = confidence interval; ERP = event-related potential; FDR = false discovery rate; IPS = intermittent photic stimulation; P/A = present/absent;
SEP = somatosensory evoked potential.
Data are reported as counts. Univariate statistics are reported based upon the χ2 test and relative effect size.
a Significant variables (based on FDR-corrected p < 0.05 rate and on 0 < V [95% CI] < 1) and relative effect sizes.
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model, since etiology was the only predictor whose coefficient
was shrunk to zero (table 5).
As the previous model was based on a subset of patients for
whom all relevant data were available, we repeated the same
statistical analyses excluding ERP as an independent variable.
The new analysis included data from 135 patients and provided
a significant final model (likelihood ratio χ2 = 72.06, df = 10, p <
0.001), with an 80.7% accuracy. In line with the previous re-
sults, this new model (table 6) showed that younger age,
shorter time postinjury, higher CRS-R total score, and presence
of EEG reactivity to eye opening at study entry were signifi-
cantly associated with a better outcome, whereas sex, etiology,
clinical diagnosis, DRS total score, EEG background activity,
Table 5 Standard logistic regression model with associated least absolute shrinkage and selection operator (LASSO)
coefficients for predicting improvement at 6-month follow-up (n = 72)
Factor Reference β LASSO β OR (95% CI)
Age −1.91 −1.10 0.14 (0.04–0.53)a
Male sex F 1.15 0.84 3.15 (0.47–21.11)
Etiology (traumatic) Nontraumatic −0.63 0 0.53 (0.06–4.42)
TPI −2.26 −1.33 0.10 (0.02–0.39)a
Diagnosis (MCS) VS/UWS −4.00 −0.94 0.01 (0.00–1.04)
CRS-R 2.20 0.66 9.10 (1.17–70.30)a
DRS −1.07 −0.45 0.34 (0.11–1.02)
EEG background (alpha) Slow −1.85 −0.79 0.15 (0.01–1.35)
EEG-R eye (present) Absent 2.30 1.33 10.04 (1.07–94.10)a
EEG-R acoustic (present) Absent 0.71 0.10 2.03 (0.22–18.43)
P300 (present) Absent 0.92 0.59 2.51 (0.37–16.80)
Abbreviations: CI = confidence interval; CRS-R = Coma Recovery Scale–Revised; DRS = Disability Rating Scale; EEG-R = EEG reactivity; MCS = minimally
conscious state; OR = odds ratio; TPI = time postinjury; VS/UWS = vegetative state/unresponsive wakefulness syndrome.
Out of 72 patients included in the analysis (VS/UWS = 33; MCS = 39), 38 improved at 6 months after brain injury (VS/UWS = 17; MCS = 21).
a Significant factors and relative OR.
Table 6 Standard logistic regression model with associated least absolute shrinkage and selection operator (LASSO)
coefficients for predicting improvement at 6-month follow-up without event-related potentials among the
independent variables (n = 135)
Factor Reference β LASSO β OR (95% CI)
Age −1.32 −0.81a 0.26 (0.12–0.54)a
Male sex F 0.85 0.60 2.35 (0.85–6.45)
Etiology (traumatic) Nontraumatic −0.46 0 0.62 (0.17–2.18)
TPI −1.30 −0.85 0.27 (0.14–0.50)a
Diagnosis (MCS) VS/UWS −1.02 0 0.36 (0.07–1.79)
CRS-R 1.29 0.58 3.64 (1.27–10.45)a
DRS −0.35 −0.17 0.70 (0.37–1.32)
EEG background (alpha) Slow 0.16 0.16 1.18 (0.41–3.36)
EEG-R eye (present) Absent 1.65 1.15 5.21 (1.45–18.75)a
EEG-R acoustic (present) Absent 0.92 0.57 2.51 (0.76–8.24)
Abbreviations: CI = confidence interval; CRS-R = Coma Recovery Scale–Revised; DRS = Disability Rating Scale; EEG-R = EEG reactivity; MCS = minimally
conscious state; OR = odds ratio; TPI = time postinjury; VS/UWS = vegetative state/unresponsive wakefulness syndrome.
Out of 135 patients included in the analysis (VS/UWS = 68; MCS = 67), 69 improved at 6 months after brain injury (VS/UWS = 26; MCS = 43).
a Significant factors and relative OR.
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and acoustic reactivity at study entry were not. In this case, the
bootstrapping procedure was only slightly biased (biases
ranging from −0.31 to 0.34). The Hosmer-Lemeshow test for
the logistic regression model indicated a good model fit (p =
0.77). Predictors in the model accounted for the 55.2% of
variability in the model (Nagelkerke pseudo-R2 = 0.552), and
AUCwas 0.88 (0.83–0.94). The LASSOmodel again provided
a similar model fit accuracy (79.2%) and eliminated from the
model only etiology and clinical diagnosis (table 6), thus cor-
roborating previous findings.
Discussion
This multicenter, prospective study enrolled a cohort of 147
patients with prolonged VS/UWS and MCS to identify prog-
nostic indices for clinical improvement at 6 months after trau-
matic or nontraumatic brain injury. As evidence of clinical
improvement, we considered both minimal improvement
(i.e., the transition from VS/UWS to MCS) and full recovery
of consciousness as study outcomes. Emergence from DoC
results in improved functioning and quality of life and is
meaningful for planning patient care and rehabilitation man-
agement. Even minimal improvement occurring by 6 months
after injury can be important for the family5 and for identifying
patients in MCS with higher likelihood of further clinical im-
provement.33 The same choice has been adopted in a recent
meta-analysis showing that neurophysiologic methods are sig-
nificantly more successful in predicting minimal improvement
(i.e., the transition fromVS/UWS toMCS) than recovery of full
consciousness.14 Our findings showed that younger age, shorter
time postinjury, higher CRS-R total score, and presence of EEG
reactivity to eye opening seem to be associated with better
outcome.
At study entry, the 2 diagnostic groups (i.e., VS/UWS and
MCS) significantly differed with regards to their level of be-
havioral responsiveness as assessed by CRS-R and DRS-R
total scores but also for responsiveness to nociceptive stimuli,
as measured by NCS-R. This last finding is consistent with
recent data showing a strong positive relation between re-
sponsiveness to nociception (i.e., NCS-R total score) and the
CRS-R total score in a cohort of patients with DoC.28
At baseline, the 2 diagnostic groups also differed significantly
for predominant EEG background activity, since poor EEG
organization was more frequently observed in patients in VS/
UWS, whereas normal and mildly abnormal EEG activities,
featuring a greater amount of alpha rhythm, were more fre-
quent in patients in MCS. These findings are consistent with
previous studies showing a possible diagnostic value of standard
EEG in patients with DoC.12,21,29,30 It is worthmentioning that
the same standardized nociceptive stimuli used in the NCS-R
protocol did not determine different EEG responses in the 2
diagnostic groups. This apparent discrepancy could be ascribed
to the use of nociceptive stimulation that was insufficient for
determining detectable changes in (EEG) cortical activity.
Indeed, it has been shown that in patients in coma, EEG re-
activity to pain can be best elicited by pain stimuli not used in
the present study.31 Future studies might take into account this
methodologic issue, and control for different types of noci-
ceptive stimulation with varying levels of intensity and site of
stimulation in patients with DoC. Finally, the P300 component
on long-latency ERPs, investigating cognitive processes such as
stimulus evaluation and categorization, was significantly more
frequent in MCS than in VS/UWS, likely owing to relatively
preserved attention abilities allowing discrimination of rare
tones in an oddball paradigm in some patients in MCS.32
In our study, prognosis at 6 months postonset was substantially
better in patients in MCS compared to patients in VS/UWS, in
terms of both clinical improvements and survival. These find-
ings are consistent with data reported in previous long-term
outcome studies on DoC.33–36 Utilizing logistic regression
analysis, we observed that younger age and shorter time since
brain injury were significant predictors of a better outcome.
Many previous studies1,10,11,36–38 found that older age was as-
sociated with a lower likelihood of recovery, likely due to lower
age-related brain plasticity39 and worse general premorbid
health conditions.40 The significant effect of time from injury at
baseline is potentially related to the fact that patients with more
severe brain injuries are usually admitted later to the re-
habilitation settings in which the large majority of the present
sample was enrolled.38,41–44
Besides these demographic and anamnestic indicators of better
outcome, we found a significant role of the CRS-R total score in
predicting better clinical evolution. The present findings sup-
ported the prognostic validity of CRS-R total score, in keeping
with previous short-term11 and long-term10,45 longitudinal
studies on individuals with DoC. Moreover, it is important to
emphasize that age, time from injury, and CRS-R total score
remained significant outcome predictors after accounting for
covariates such as clinical diagnosis, etiology of brain injury, and
functional disability level, which were considered significant
outcome predictors in previous studies.1,6,33,36–38,41,42
One important finding of the present study was that EEG
reactivity to eye opening, but not presence of P300 on ERP,
discriminated patients who improved from patients who did
not improve or had died at 6 months after the brain injury. A
recent meta-analysis14 on empirical studies investigating the
prognostic parameters of neurophysiologic variables (including
EEG and ERP) highlighted that overall neurophysiologic data
predicted the transition from VS/UWS to MCS substantially
better than the transition from VS/UWS or MCS to emer-
gence fromMCS (i.e., the recovery of consciousness), whereas
EEG changes to different kinds of stimuli and tasks were the
only significant predictors in studies in which the 2 improve-
ment criteria were considered cumulatively. Thus, the present
study fits with the meta-analysis conclusion, since EEG re-
activity predicted the 2 improvement criteria (i.e., “improved”
outcome included minimal clinical improvement and regaining
full consciousness). The temporary EEG alpha blocking in
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response to eye opening is related to basic thalamo-cortical
system46 thought to be involved in consciousness circuitry.47
The present findings are inconsistent with previous outcome
studies showing that the presence of P300 on ERP can help
clinicians to predict the recovery of consciousness in indi-
viduals with DoC.48,49 The poor prognostic value of ERP in
our cohort of patients might be ascribed to the lower number
of patients in whom ERPs were recorded (n = 75) or to the
fact that an association of ERP with outcome at univariate
analysis decreased in the regression analysis in which other
strong predictors were simultaneously entered.
The present study has several limitations. First, the relatively small
sample size did not allow us to search for predictors of outcome
in the 2 diagnostic groups (i.e., VS/UWS and MCS) separately.
For the same reason, we could not compare the prognostic fac-
tors for the 3 possible conditions of outcome (recovery of con-
sciousness for patients in MCS, recovery of consciousness for
patients in VS/UWS, and transition to MCS for patients in VS/
UWS), whereas it has been shown that prognostic factors might
differentially affect each of them.14 Future multicenter studies
should enroll a larger sample of patients to address these issues.
Second, neurophysiologic findings were not available in a rel-
atively small group of patients (i.e., EEG background activity =
8; EEG reactivity to eye opening = 9, to tactile stimuli = 17, to
acoustic stimuli = 7, to nociceptive stimuli = 18, to IPS = 14;
SEP = 61; ERP = 72) mainly because of logistical challenges
(e.g., lack of dedicated equipment, human resources, or time
constraints) and technical issues (e.g., movement artifacts).
Notwithstanding this limitation, we continue to promote the
use of multimodal neurophysiologic evaluations whenever
possible for improving prognostication in patients with DoC.
Further studies might also consider using self-referential au-
ditory stimuli (e.g., patient’s own name) as target stimuli in
the ERP oddball paradigm. The oddball paradigm used here
(rare vs frequent tones) could discriminate patients of the 2
groups at baseline and had a univariate association with better
outcome, but self-referential stimuli could be more efficient
for eliciting the P300 in patients with DoC.32,48,50
This study represents a first international, multicenter attempt to
concurrently evaluate the prognostic value of demographic, an-
amnestic, clinical, and neurophysiologic data in patients with
prolonged DoC. By applying standardized multimodal assess-
ment protocols in patients in VS/UWS and MCS, we found
that younger age, shorter time postinjury, higher level of
responsiveness/consciousness, as measured by the CRS-R total
score, and presence of EEG reactivity to eye opening could
predict better outcome at 6 months after severe brain injury.
These prognostic factors are feasible to record in intensive and
rehabilitation care settings, can be analyzed by trained medical
professionals without sophisticated technical tools, can be re-
peated at bedside, and are not time-consuming or expensive. The
prognostic value of such indices should be investigated at 12
months and 24months after onset to determine their relevance in
predicting longer-term outcomes. This multicenter international
study will hopefully serve as a starting point to stimulate further
research that drives international consensus regarding standard-
ization of prognostic procedures in the clinical care of individuals
with prolonged DoC. Such prognostic procedures could help
clinicians to identify people with DoC most suitable for tailored
rehabilitation programs and therapeutic interventions.
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